Suberoylanilide hydroxamic acid (Zolinza/vorinostat) sensitizes TRAIL-resistant breast cancer cells orthotopically implanted in BALB/c nude mice
Molecular Cancer Therapeutics (2009) - Comments
pubmed: 19509267  doi: 10.1158/1535-7163.mct-08-1004  issn: 1538-8514  issn: 1535-7163 

Sharmila Shankar, Rachel Davis, Karan P. Singh, Razelle Kurzrock, Douglas D. Ross, Rakesh K. Srivastava